Investigational 23-valent PPV
PRO-PPV-4001
Approved mab completed
Quick answer
Investigational 23-valent PPV for Pneumococcal Infections is a Approved program (mab) at SINOVAC BIOTECH LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- SINOVAC BIOTECH LTD
- Indication
- Pneumococcal Infections
- Phase
- Approved
- Modality
- mab
- Status
- completed